GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acorda Therapeutics Inc (FRA:CDG) » Definitions » Cyclically Adjusted Book per Share

Acorda Therapeutics (FRA:CDG) Cyclically Adjusted Book per Share : €0.00 (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Acorda Therapeutics Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Acorda Therapeutics's adjusted book value per share for the three months ended in Mar. 2024 was €-137.597. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Acorda Therapeutics's average Cyclically Adjusted Book Growth Rate was -9.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -1.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Acorda Therapeutics was 16.80% per year. The lowest was -1.60% per year. And the median was 5.30% per year.

As of today (2024-06-08), Acorda Therapeutics's current stock price is €8.423. Acorda Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.00. Acorda Therapeutics's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Acorda Therapeutics was 10.83. The lowest was 0.01. And the median was 0.27.


Acorda Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Acorda Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acorda Therapeutics Cyclically Adjusted Book per Share Chart

Acorda Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,496.04 1,079.88 1,163.63 1,110.83 -

Acorda Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,165.74 872.94 741.70 - -

Competitive Comparison of Acorda Therapeutics's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Acorda Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acorda Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Acorda Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Acorda Therapeutics's Cyclically Adjusted PB Ratio falls into.



Acorda Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Acorda Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-137.597/131.7762*131.7762
=-137.597

Current CPI (Mar. 2024) = 131.7762.

Acorda Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 1,076.304 100.560 1,410.421
201409 1,180.829 100.428 1,549.423
201412 1,255.687 99.070 1,670.235
201503 1,422.785 99.621 1,882.023
201506 1,398.160 100.684 1,829.927
201509 1,433.559 100.392 1,881.723
201512 1,545.355 99.792 2,040.646
201603 1,603.684 100.470 2,103.380
201606 1,556.297 101.688 2,016.784
201609 1,545.336 101.861 1,999.180
201612 1,654.593 101.863 2,140.489
201703 1,622.428 102.862 2,078.484
201706 1,579.363 103.349 2,013.781
201709 1,465.858 104.136 1,854.939
201712 1,135.724 104.011 1,438.898
201803 1,146.944 105.290 1,435.470
201806 1,321.794 106.317 1,638.320
201809 1,303.443 106.507 1,612.694
201812 1,361.270 105.998 1,692.326
201903 1,267.515 107.251 1,557.366
201906 1,217.998 108.070 1,485.185
201909 637.341 108.329 775.287
201912 703.726 108.420 855.324
202003 698.144 108.902 844.789
202006 649.806 108.767 787.268
202009 665.936 109.815 799.113
202012 413.092 109.897 495.335
202103 365.912 111.754 431.468
202106 284.694 114.631 327.274
202109 249.913 115.734 284.553
202112 201.984 117.630 226.276
202203 174.424 121.301 189.487
202206 68.524 125.017 72.229
202209 62.898 125.227 66.188
202212 72.628 125.222 76.430
202303 59.069 127.348 61.123
202306 50.432 128.729 51.626
202309 44.475 129.860 45.131
202312 -116.614 129.419 -118.738
202403 -137.597 131.776 -137.597

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Acorda Therapeutics  (FRA:CDG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Acorda Therapeutics was 10.83. The lowest was 0.01. And the median was 0.27.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Acorda Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Acorda Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Acorda Therapeutics (FRA:CDG) Business Description

Traded in Other Exchanges
Address
2 Blue Hill Plaza, 3rd Floor, Pearl River, New York, NY, USA, 10965
Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija is for as-needed use and utilizes the ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. The company also markets branded Ampyra (dalfampridine) Extended-Release Tablets, 10 mg to improve walking in adults with multiple sclerosis.

Acorda Therapeutics (FRA:CDG) Headlines

No Headlines